Ticker
EBSCompany Name
EMERGENT BIOSOLUTIONS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 1.42B | $ 139.5M | 9.84% |
3/31/2025 | $ 1.43B | $ -131.6M | -9.23% |
12/31/2024 | $ 1.39B | $ -190.6M | -13.72% |
9/30/2024 | $ 1.48B | $ -208.8M | -14.13% |
6/30/2024 | $ 1.51B | $ -587M | -38.78% |
3/31/2024 | $ 1.8B | $ -565.2M | -31.34% |
12/31/2023 | $ 1.82B | $ -760.5M | -41.71% |
9/30/2023 | $ 1.89B | $ -774.7M | -40.92% |
6/30/2023 | $ 2.18B | $ -608M | -27.91% |
3/31/2023 | $ 2.95B | $ -403.1M | -13.67% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for EMERGENT BIOSOLUTIONS INC is calculated as follows: Net Inc. Cmn. [ $ 166.6M ] / Assets [ $ 2.62B ]
(=) ROA [ 6.37% ]
Minimum
Dec 31, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.45K |
---|---|
min | -33.42% |
max | 33.98% |
average | 0.1% |
median | 1.53% |
std | 10.63% |